Experimental Hematology
Volume 34, Issue 8 , Pages 1060-1068 , August 2006

G-CSF- and GM-CSF-induced upregulation of CD26 peptidase downregulates the functional chemotactic response of CD34+CD38− human cord blood hematopoietic cells

  • Kent W. Christopherson II

      Affiliations

    • Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, Tex., USA
    • Corresponding Author InformationOffprint requests to: Kent W. Christopherson II, Ph.D., Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, 2121 W. Holcombe Blvd., Houston, Texas 77030
    • ,
  • Sherene E. Uralil

      Affiliations

    • Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, Tex., USA
    • ,
  • Nehal K. Porecha

      Affiliations

    • Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, Tex., USA
    • ,
  • Ryan C. Zabriskie

      Affiliations

    • Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, Tex., USA
    • ,
  • Shannon M. Kidd

      Affiliations

    • Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, Tex., USA
    • ,
  • Susan M. Ramin

      Affiliations

    • Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Texas–Houston Medical School, Houston, Tex., USA

References 

  1. Juttner CA, To LB, Haylock DN, Branford A, Kimber RJ. Circulating autologous stem cells collected in very early remission from acute non-lymphoblastic leukaemia produce prompt but incomplete haemopoietic reconstitution after high dose melphalan or supralethal chemoradiotherapy. Br J Haematol. 1985;61:739–745
  2. Reiffers J, Bernard P, David B, et al. Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with acute leukemia. Exp Hematol. 1986;14:312–315
  3. To LB, Roberts MM, Haylock DN, et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant. 1992;9:277–284
  4. Duhrsen U, Villeval JL, Boyd J, Kannourakis G, Morstyn G, Metcalf D. Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood. 1988;72:2074–2081
  5. Socinski MA, Cannistra SA, Elias A, Antman KH, Schnipper L, Griffin JD. Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet. 1988;1:1194–1198
  6. Molineux G, Migdalska A, Szmitkowski M, Zsebo K, Dexter TM. The effects on hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte colony-stimulating factor. Blood. 1991;78:961–966
  7. Brasel K, McKenna HJ, Morrissey PJ, et al. Hematologic effects of flt3 ligand in vivo in mice. Blood. 1996;88:2004–2012
  8. Orazi A, Cattoretti G, Schiro R, et al. Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrow. Blood. 1992;79:2610–2619
  9. Appelbaum FR. Allogeneic marrow transplantation and the use of hematopoietic growth factors. Stem Cells. 1995;13:344–350
  10. Rutella S, Rumi C, Sica S, Leone G. Recombinant human granulocyte colony-stimulating factor (rHuG-CSF): effects on lymphocyte phenotype and function. J Interferon Cytokine Res. 1999;19:989–994
  11. De Witte T, Gratwohl A, Van Der Lely N, et al. Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depleted bone marrow transplantation. Blood. 1992;79:1359–1365
  12. Masaoka T, Takaku F, Kato S, et al. Recombinant human granulocyte colony-stimulating factor in allogeneic bone marrow transplantation. Exp Hematol. 1989;17:1047–1050
  13. Rosenfeld C, Collins R, Pineiro L, Agura E, Nemunaitis J. Allogeneic blood cell transplantation without posttransplant colony-stimulating factors in patients with hematopoietic neoplasm: a phase II study. J Clin Oncol. 1996;14:1314–1319
  14. Bensinger WI, Longin K, Appelbaum F, et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol. 1994;87:825–831
  15. Martin-Algarra S, Bishop MR, Tarantolo S, et al. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs-host disease prophylaxis. Exp Hematol. 1995;23:1503–1508
  16. Khoury HJ, Loberiza FR, Ringden O, et al. Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation. Blood. 2006;107:1712–1716
  17. Broxmeyer HE, Douglas GW, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A. 1989;86:3828–3832
  18. Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989;321:1174–1178
  19. Wagner JE. Umbilical cord blood transplantation: overview of the clinical experience. Blood Cells. 1994;20:227–233
  20. Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE, Gluckman E. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet. 1995;346:214–219
  21. Shpall EJ, Quinones R, Giller R, et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant. 2002;8:368–376
  22. Guenechea G, Segovia JC, Albella B, et al. Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo–expanded human CD34+ cord blood cells. Blood. 1999;93:1097–1105
  23. Xu R, Reems JA. Umbilical cord blood progeny cells that retain a CD34+ phenotype after ex vivo expansion have less engraftment potential than unexpanded CD34+ cells. Transfusion. 2001;41:213
  24. Breems DA, Blokland EA, Siebel KE, Mayen AE, Engels LJ, Ploemacher RE. Stroma-contact prevents loss of hematopoietic stem cell quality during ex vivo expansion of CD34+ mobilized peripheral blood stem cells. Blood. 1998;91:111–117
  25. McNiece I, Harrington J, Turney J, Kellner J, Shpall EJ. Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells. Cytotherapy. 2004;6:311–317
  26. Lemischka IR, Moore KA. Stem cells: interactive niches. Nature. 2003;425:778–779
  27. Fuchs E, Tumbar T, Guasch G. Socializing with the neighbors: stem cells and their niche. Cell. 2004;116:769–778
  28. Bongers J, Lambros T, Ahmad M, Heimer EP. Kinetics of dipeptidyl peptidase IV proteolysis of growth hormone–releasing factor and analogs. Biochim Biophys Acta. 1992;1122:147–153
  29. Lambeir AM, Proost P, Durinx C, et al. Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family. J Biol Chem. 2001;276:29839–29845
  30. Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med. 1997;185:111–120
  31. Christopherson KW, Broxmeyer HE. Hematopoietic stem and progenitor cell homing, engraftment, and mobilization in the context of the CXCL12/SDF-1-CXCR4 axis. In:  Broxmeyer HE editors. Cord Blood: Biology, Immunology, Banking, and Clinical Transplantation. Bethesda, MD: AABB Press; 2004;p. 65–86
  32. Peled A, Petit I, Kollet O, et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science. 1999;283:845–848
  33. Petit I, Szyper-Kravitz M, Nagler A, et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol. 2002;3:687–694
  34. Cashman J, Clark-Lewis I, Eaves A, Eaves C. Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice. Blood. 2002;99:792–799
  35. Lataillade JJ, Clay D, Dupuy C, et al. Chemokine SDF-1 enhances circulating CD34+ cell proliferation in synergy with cytokines: possible role in progenitor survival. Blood. 2000;95:756–768
  36. Broxmeyer HE, Kohli L, Kim CH, et al. Stromal cell–derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and Gαi proteins and enhances engraftment of competitive, repopulating stem cells. J Leukoc Biol. 2003;73:630–638
  37. Crump MP, Gong JH, Loetscher P, et al. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J. 1997;16:6996–7007
  38. Christopherson KW, Hangoc G, Broxmeyer HE. Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell–derived factor-1 α–mediated chemotaxis of human cord blood CD34+ progenitor cells. J Immunol. 2002;169:7000–7008
  39. Christopherson KW, Cooper S, Broxmeyer HE. Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells. Blood. 2003;101:4680–4686
  40. Christopherson KW, Cooper S, Hangoc G, Broxmeyer HE. CD26 is essential for normal G-CSF-induced progenitor cell mobilization as determined by CD26−/− mice. Exp Hematol. 2003;31:1126–1134
  41. Christopherson KW, Hangoc G, Mantel CR, Broxmeyer HE. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science. 2004;305:1000–1003
  42. Tian C, Bagley J, Forman D, Iacomini J. Inhibition of CD26 peptidase activity significantly improves engraftment of retrovirally transduced hematopoietic progenitors. Gene Ther. 2006;13:652–658
  43. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔC(T) method. Methods. 2001;25:402–408
  44. Bogenrieder T, Finstad CL, Freeman RH, et al. Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue. Prostate. 1997;33:225–232
  45. Wilson MJ, Ruhland AR, Pryor JL, et al. Prostate specific origin of dipeptidylpeptidase IV (CD-26) in human seminal plasma. J Urol. 1998;160:1905–1909

PII: S0301-472X(06)00233-5

doi: 10.1016/j.exphem.2006.03.012

Experimental Hematology
Volume 34, Issue 8 , Pages 1060-1068 , August 2006

Article Tools

* Image Usage & Resolution